United States Patent (19) 11 Patent Number: 5,714,481 Schwartz Et Al
USOO5714481A United States Patent (19) 11 Patent Number: 5,714,481 Schwartz et al. 45 Date of Patent: Feb. 3, 1998 54). DERIVATIVES OF 5-ANDROSTEN-17 ONES OTHER PUBLICATIONS AND SANDROSTAN-17-ONES Rao et al. Cancer Research (51), 4528–4534, Sep. 1, 1991. 75 Inventors: Arthur G. Schwartz, Philadelphia; Schwartz et al. Carcinogenesis, vol. 10, No. 10, 1809-1813, John R. Williams, Merion, both of Pa.; 1989. Magid Abou-Gharbia, Wilmington, Ratko et al. Cancer Research (51), 481-486. Jan. 15, 1991. Del.; Daniel Swern, deceased, late of Schwartz. Nutr Cancer, 3.46-53 (1981). Elkins Park, Pa., by Ann R. Swern, Fels Ann. Report 1979-1980 pp. 32-33. Executrix: Marvin Louis Lewbart, Pashko, Chem. Abs. 101315K (1984). Media, Pa. Schwartz, et al. Chen Abs. 103, 123791 m (1985). 73) Assignee: Research Corporation Technologies, Robinson, et al., J. Org. Chem. 28,975-980 (1963). Inc., Tucson, Ariz. Hanson, et al. Perkin Transactions I, 499-501 (1977). Goldman, et al. Biochimica and Biophysics Acta, 233-249 (21) Appl. No.: 456,269 (1973). Pashko, et al., Carcinogenesis, 2, 717-721 (1981). 22 Filed: May 31, 1995 Abou-Gharbia et al., Journal of Pharmaceutical Sciences, Related U.S. Application Data 70, 1154 (1981). Raineri and Levy, Biochemistry 9, 233-2243 (1970). 63 Continuation of Ser. No. 49,752, Apr. 19, 1993, abandoned, Pelic, et al., Collection Czechoslov, Chem. Comm., 31, 1064 which is a continuation of Ser. No. 826,349, Jan. 27, 1992, (1966). abandoned, which is a continuation of Ser. No. 615,758, Jan. 19, 1990, abandoned, which is a continuation of Ser.
[Show full text]